Verwandte Artikel zu Tamoxifen & Breast Cancer (Yale Fastback Series)
Inhaltsangabe
Book by DeGregorio Dr Michael W Wiebe Valerie J
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Reseña del editor
Tamoxifen is one of the most widely prescribed drugs used to prevent the recurrence of breast cancer. A nonsteroidal antiestrogen, it has been successful in treating postmenopausal women at nearly all stages of breast cancer. Despite its popularity, disturbing questions remain about the use of this drug. How effective is tamoxifen in treating patients who have hormone-insensitive breast tumors or who have not yet reached menopause? What are the potential risks in taking tamoxifen, and do they ever outweigh its benefits? Should tamoxifen be administered as a prophylactic drug for healthy premenopausal women who are at high risk of developing breast cancer? In this vitally important book, two leading scientific investigators present a balanced and accessible discussion of the diagnosis of breast cancer and the risks, benefits, and limitations of treatment alternatives, particularly tamoxifen. Michael W. DeGregorio and Valerie J. Wiebe discuss the history and evolution of tamoxifen as a treatment for breast cancer, explaining how it works, what its side effects are, and why tamoxifen treatment is unsuccessful for some women. They present the controversies surrounding the National Cancer Institute's study of tamoxifen as a preventive for breast cancer, describing the hopes of the proponents of the study and the fears of its detractors (potential risks to women in the study include thrombosis, uterine cancer, and even breast cancer itself). The book is an invaluable aid to women faced with decisions about treatment or prevention of breast cancer.
Reseña del editor
This authoritative and timely book presents a balanced and accessible discussion of the diagnosis of breast cancer and the risks, benefits, and limitations of treatment alternatives, particularly tamoxifen. For this revised edition, the authors have added new information regarding the latest developments in the use of tamoxifen, especially the results of the Breast Cancer Prevention Trial. Other current issues discussed are raloxifene in chemoprevention, the use of hormone replacement therapy in breast cancer, new biologic agents, and other prevention strategies.
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
- VerlagYale University Press
- Erscheinungsdatum1999
- ISBN 10 0300079516
- ISBN 13 9780300079517
- EinbandTapa blanda
- Anzahl der Seiten130
Neu kaufen
Mehr zu diesem Angebot erfahren
EUR 29,64
Versand:
EUR 48,99
Von Deutschland nach USA
Weitere beliebte Ausgaben desselben Titels
Beste Suchergebnisse beim ZVAB
Beispielbild für diese ISBN
Tamoxifen & Breast Cancer 2e (Yale Fastback Series)
Anbieter: WorldofBooks, Goring-By-Sea, WS, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
Paperback. Zustand: Very Good. The book has been read, but is in excellent condition. Pages are intact and not marred by notes or highlighting. The spine remains undamaged. Artikel-Nr. GOR003185300
Anzahl: 1 verfügbar
Beispielbild für diese ISBN
Tamoxifen & Breast Cancer
Anbieter: Anybook.com, Lincoln, Vereinigtes Königreich
Verkäuferbewertung 5 von 5 Sternen
Zustand: Good. This is an ex-library book and may have the usual library/used-book markings inside.This book has soft covers. In good all round condition. Artikel-Nr. 8737245
Anzahl: 1 verfügbar
Beispielbild für diese ISBN
Tamoxifen and Breast Cancer
Anbieter: Robinson Street Books, IOBA, Binghamton, NY, USA
Verkäuferbewertung 4 von 5 Sternen
Paperback. Zustand: Very Good. Prompt shipment, with tracking. we ship in CLEAN SECURE BOXES NEW BOXES Medical Research; Very good trade paperback. Minor crease and nicking to cover. Clean pages. Prompt shipping with tracking. Artikel-Nr. lower29as063
Anzahl: 1 verfügbar
Foto des Verkäufers
DeGregorio, M: Tamoxifen & Breast Cancer
Anbieter: moluna, Greven, Deutschland
Verkäuferbewertung 5 von 5 Sternen
Zustand: New. A discussion of the diagnosis of breast cancer and the risks, benefits and limitations of treatment alternatives, particularly tamoxifen. This edition contains information on developments in the use of tamoxifen, especially in the results of the Breast Canc. Artikel-Nr. 594503207
Anzahl: Mehr als 20 verfügbar